Ameriprise Portfolio holdings
Ameriprise Financial, Inc., founded in 1894 as Investors Syndicate and headquartered in Minneapolis, Minnesota, is a leading financial services firm specializing in wealth management, financial planning, and insurance, managing hundreds of billions in assets for individual and institutional clients. Evolving from its roots in investment certificates, it now offers a comprehensive suite of services, including retirement planning, annuities, mutual funds, and advisory solutions, delivered through a network of over 10,000 financial advisors across the U.S. Known for its client-first approach, Ameriprise became independent in 2005 after spinning off from American Express, focusing on personalized advice and robust digital tools to compete in a crowded market. With a strong emphasis on long-term relationships and financial security, Ameriprise has grown into a trusted name in the retail investment and insurance sectors.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
UnitedHealth
UNH
|
+$456M |
| 2 |
SW
Smurfit Westrock
SW
|
+$403M |
| 3 |
Walt Disney
DIS
|
+$391M |
| 4 |
Vanguard FTSE Developed Markets ETF
VEA
|
+$345M |
| 5 |
EPAM Systems
EPAM
|
+$305M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$671M |
| 2 |
Nike
NKE
|
+$557M |
| 3 |
Microchip Technology
MCHP
|
+$544M |
| 4 |
Visa
V
|
+$535M |
| 5 |
Becton Dickinson
BDX
|
+$487M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 24.06% |
| 2 | Financials | 10.52% |
| 3 | Healthcare | 9.63% |
| 4 | Industrials | 8.45% |
| 5 | Consumer Discretionary | 7.85% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3801
PMV Pharmaceuticals
PMVP
$59.2M
| $58.9K | ﹤0.01% |
39,522
-10,272
| -21% | -$15.9K |
|
|
ACCD
3802
DELISTED
Accolade Inc
ACCD
| $58.3K | ﹤0.01% |
15,142
-94,456
| -86% | -$370K |
|
3803
Silicon Motion
SIMO
$8.6B
| $58K | ﹤0.01% |
954
-2,431
| -72% | -$160K |
|
|
YALA
3804
Yalla Group
YALA
$818M
| $57.4K | ﹤0.01% |
+12,653
| New | +$53K |
|
3805
Erasca
ERAS
$6.3B
| $57.1K | ﹤0.01% |
20,928
-152,875
| -88% | -$431K |
|
3806
AMC Entertainment Holdings
AMC
$2.52B
| $56.9K | ﹤0.01% |
+12,498
| New | +$62.3K |
|
3807
ICL Group
ICL
$6.53B
| $50.9K | ﹤0.01% |
11,973
+859
| +8% | +$3.64K |
|
3808
Clean Energy Fuels
CLNE
$427M
| $46.8K | ﹤0.01% |
15,050
-400
| -3% | -$1.13K |
|
3809
GrowGeneration
GRWG
$86.5M
| $46.6K | ﹤0.01% |
21,874
+10
| +0% | +$21 |
|
3810
Petco
WOOF
$797M
| $45.9K | ﹤0.01% |
10,082
-255
| -2% | -$866 |
|
3811
Cardlytics
CDLX
$21.7M
| $44.3K | ﹤0.01% |
1,386
-468
| -25% | -$26K |
|
|
NRO
3812
Neuberger Real Estate Securities Income Fund Inc
NRO
$191M
| $42.6K | ﹤0.01% |
+10,855
| New | +$38.6K |
|
|
NXDR
3813
Nextdoor Holdings
NXDR
$847M
| $42.2K | ﹤0.01% |
16,997
-740
| -4% | -$1.9K |
|
|
AKYA
3814
DELISTED
Akoya BioSciences
AKYA
| $41.6K | ﹤0.01% |
15,300
-4,400
| -22% | -$10.7K |
|
|
ME
3815
DELISTED
23andMe Holding Co
ME
| $39.9K | ﹤0.01% |
5,741
+130
| +2% | +$970 |
|
3816
TherapeuticsMD
TXMD
$23.5M
| $37.3K | ﹤0.01% |
22,470
| – | – |
|
3817
Mobile Infrastructure Corp
BEEP
$75.4M
| $36.6K | ﹤0.01% |
+11,168
| New | +$34.9K |
|
|
GBIO
3818
DELISTED
Generation Bio
GBIO
| $35.3K | ﹤0.01% |
1,427
-350
| -20% | -$9.26K |
|
3819
Oxbridge Re Holdings
OXBR
$10.6M
| $27.8K | ﹤0.01% |
10,000
| – | – |
|
3820
ChargePoint
CHPT
$141M
| $25.1K | ﹤0.01% |
914
+307
| +51% | +$10.7K |
|
3821
Aemetis
AMTX
$106M
| $24.1K | ﹤0.01% |
10,460
-17,240
| -62% | -$48.3K |
|
3822
Polestar Automotive Holding UK
PSNY
$2.09B
| $22.4K | ﹤0.01% |
+434
| New | +$14K |
|
3823
Lineage Cell Therapeutics
LCTX
$269M
| $21.3K | ﹤0.01% |
23,500
-160
| -0.7% | -$148 |
|
3824
Vuzix
VUZI
$194M
| $20.2K | ﹤0.01% |
17,300
| – | – |
|
|
VTNR
3825
DELISTED
Vertex Energy, Inc
VTNR
| $19.3K | ﹤0.01% |
166,635
-341,000
| -67% | -$189K |
|
Similar funds
Ameriprise's Q3 2024 Portfolio in Review
As of Q3 2024, Ameriprise held 4,064 positions worth $390B, up 5.5% from $370B the previous quarter. Its ten largest holdings account for 19% of the portfolio.
Ameriprise's Q3 2024 filing shows 197 new, 1,617 increased, 1,938 reduced and 141 closed positions. Its largest new stake was Smurfit Westrock: 8,854,270 shares worth $438M. The largest sale was Apple, an estimated $671M.
By sector, the portfolio is most concentrated in Technology at 24% of assets, down from 25% a quarter earlier, followed by Financials and Healthcare.
- Ameriprise's largest Q3 2024 buy was Smurfit Westrock: 8,854,270 shares worth $438M.
- Ameriprise added most to UnitedHealth in Q3 2024, an estimated $456M increase.
- Ameriprise's biggest Q3 2024 reduction was Apple, cutting an estimated $671M.
- Ameriprise fully exited Cerevel Therapeutics Holdings, Inc. Common Stock in Q3 2024, selling an estimated $55.1M.
- Ameriprise's ten largest holdings make up 19% of its $390B portfolio in Q3 2024.
- Ameriprise opened 197 new positions and closed 141 in Q3 2024.
- Ameriprise's portfolio value rose 5.5% quarter-over-quarter to $390B.
Based on Ameriprise's 13F filing for Q3 2024, filed 14 Nov 2024.